GlassScriptPhysician profile
Sunny Kumar
NPI 1922596014
$1,012.21
in general payments reported to CMS, 2019-2025
18 companies · $700 in 2025
The $700 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.80 · 2021: $48.59 · 2024: $247 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Entertainment: $36.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.64 |
| Entertainment | $36.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $200.37 | 2024-2025 | Verquvo, Winrevair |
| Abiomed | $176.93 | 2024-2025 | Impella |
| Amgen INC. | $102.53 | 2024-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $97.91 | 2025 | Attruby |
| Pfizer INC. | $76.89 | 2025 | |
| Abbvie INC. | $54.44 | 2021-2024 | |
| Becton, Dickinson and Company | $47.94 | 2025 | |
| Chiesi USA, INC. | $40.72 | 2024-2025 | Juxtapid, Kengreal |
| Stereotaxis INC | $36.18 | 2025 | Genesis |
| Regeneron Healthcare Solutions, INC. | $29.44 | 2025 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $28.04 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $21.09 | 2025 | Wainua |
| Lexicon Pharmaceuticals, INC. | $19.49 | 2024 | |
| Angiodynamics, INC. | $18.85 | 2025 | Alphavac |
| Viiv Healthcare Company | $16.80 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $15.69 | 2024 | Arcalyst |
| Deciphera Pharmaceuticals INC. | $15.45 | 2021 | |
| Clovis Oncology, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunny Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.